Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
4.38Price to Sales
VS
Market
Sector
Industry
History
$ 4.15Close
$ 4.04 - $ 16.8 52-Week Range
Ticker Information
Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVERRICA PHARMACEUTICALS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VRCA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 64.42M | 4.38 | $ 14.7M |
| 3/31/2025 | $ 50.87M | 7.09 | $ 7.18M |
| 12/31/2024 | $ 59.49M | 7.86 | $ 7.57M |
| 9/30/2024 | $ 36.37M | 3.95 | $ 9.21M |
| 6/30/2024 | $ 133.13M | 9.57 | $ 13.91M |
| 3/31/2024 | $ 405.54M | 45.5 | $ 8.91M |
| 12/31/2023 | $ 223.55M | 43.63 | $ 5.12M |
| 9/30/2023 | $ 135.03M | 42.14 | $ 3.2M |
| 6/30/2023 | $ 222.52M | 25.86 | $ 8.61M |
| 3/31/2023 | $ 274.4M | 31.77 | $ 8.64M |
Key Performance Insights, Last 5 Years
- VERRICA PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, VERRICA PHARMACEUTICALS INC's average P/S has been 54.78.
- The median P/S for VERRICA PHARMACEUTICALS INC during this period was 26.12
- VERRICA PHARMACEUTICALS INC reached its highest P/S over the past 5 years at 388.2.
- The lowest P/S recorded by VERRICA PHARMACEUTICALS INC in the same timeframe 3.95
VERRICA PHARMACEUTICALS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for VERRICA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 202.79M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] VRCA - Price to Sales, Last 5 years
3.95
Minimum
Sep 30, 2024
388.2
Maximum
Mar 31, 2022
54.78
Average
26.12
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |